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In a recent paper, Hutter and Benner now appear toOrthogonal Base Pairs
have solved this problem [7]. 6-Amino-2-oxo-(1H) pyri-Continue to Evolve dine linked C3 to C1 of 2-deoxyribose is prone to epi-
merization through a mechanism initiated by proton-
ation of the furanose oxygen followed by furanose ring
opening coordinated with loss of the proton on N1. Re-
Recent developments in the design and construction closure leads to both the  and 
 epimers about C1.
of unusual analogs of the natural nucleic acid bases Hutter and Benner rationalized that the introduction of
have reached a milestone with the report (in this issue a strong electron withdrawing group at C5 would pre-
of Chemistry & Biology [1]) of a new orthogonal base vent the electron release required for ring opening. In-
pair that allows site-specific introduction of a photo- deed they have now demonstrated that the iso-C analog,
crosslinkable modified base into an RNA molecule by 6-amino-3-(2-deoxy-
-D-ribofuranosyl)-5-nitro-(1H)-
T7 RNA polymerase-mediated transcription of DNA pyridine-2-one is stable to epimerization under condi-
containing the base-pairing partner. tions that one typically encounters during synthesis and
manipulation of nucleoside triphosphates and oligonu-
One of the more interesting challenges in modified base cleotides. One can expect that this work will soon be
design has been the creation of new orthogonal base extended to polymerase-mediated nucleic acid repli-
pairs that would function as substrates for enzymes cation.
involved in the synthesis and processing of nucleic acids As an alternative to orthogonal hydrogen bonding nu-
and would thereby provide a means for the expansion cleoside analogs, Kool and coworkers have been explor-
of the genetic code [2]. The earliest concerted effort to ing nonhydrogen-bonding isosteres of the natural bases
expand the genetic code and create new base pairs [8]. A critical finding from this laboratory was that the
came from the laboratory of Benner and coworkers. In hydrophobic shape-complementary purine-pyrimidine
studies initiated during the 1980s, a series of putative analogs preferentially pair with one another [9, 10]. Oth-
base pairs containing alternative orthogonal hydrogen ers variations on this theme have uncovered a number
bonding patterns were designed and synthesized [3, 4]. of interesting new base pairs. Most noteworthy has been
Although the initial results with the isoC-isoG base pair the effort by Romesberg, Schultz, and coworkers, who
looked promising, subsequent work showed that isoC have focused on the theme of creating unique hydropho-
was unstable in aqueous solution [5]. Furthermore, dif- bic base analogs with significant preference for self-
ferent polymerases show a broad range of specificity pairing in nucleic acid duplexes [11].
and recognition characteristics with these bases as tem- Recently Hirao and coworkers reported a strategy for
plate and as triphosphate substrates. In subsequent the construction of orthogonal base pairs that depend
years the Benner laboratory continued to explore new more on molding complementary shapes rather than
variations on alternative H-bonding pattern modified hydrogen bonding pattern [12, 13]. They have found
bases. These studies included C-linked pyrimidine ana- pairing specificity between a purine bearing a nonhydro-
logs [4, 6], which although optimal from the standpoint gen-bonding substituent on C6 of a purine and a pyridine
of alternative H-bonding patterns, proved to be unstable C-nucleoside that mimics a pyrimidine nucleoside minus
the C4 amino or oxo group. This pairing is illustrated intoward epimerization at C1.
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Figure 1 for a purine containing C2 amino and C6 thienyl
groups and the pyridine a C5 iodo group [1]. This pair
appears to be able to occupy space without deviating
significantly from the natural parameters (shown for a
G•C base pair in the figure). Comparison to a natural
G•C base pair indicates that the space defined by this
pair could have a slightly shorter C1 to C1 distance
and modestly higher angles for 	. The size and geometry
of the thienyl group suggest that there is not much differ-
ence between the two possible conformations about
the bond between the purine C6 and thiophene C2.
Indeed a simple AM1 calculation predicts less than 0.3
kcal difference between the two conformations.
In the design of new base pairs, there are certain
structural properties that appear to be universally re-
quired if a base pair is to be incorporated and extended
by polymerases. These include the presence of a planar
aromatic moiety, a shape that matches an A•U(T) or
G•C base pair and hydrogen bond acceptor sites on
the minor groove side of each base positioned in space
equivalent to O2 of C or U(T) and N3 of A or G. Protruding
groups extending beyond the dimensions of a natural
base pair are not tolerated, with one important excep-
tion. Substituents that protrude into the major groove
from C5 of the pyrimidine nucleosides appear to be
accommodated. This exception is important because it
allows one to place modifications into nucleic acids by
enzyme-mediated reactions. Kimoto et al. [1] exploit
polymerase tolerance for substituents in this region.
Both of the modified bases in the s•Iy base pair contain
modifications that protrude into the major groove. In the
case of the thienylpurine analog, s, the presence of the
thienyl sterically excludes the four natural nucleosides
but accommodates an analog, 2-oxo-(1H)pyridine (Iy),
that lacks a substituent at the site occupied by O4 in U Figure 1. Comparison of the Structures of a G•C Base Pair and the
and the external NH2 in C. There is the prospect that Orthogonal s•Iy Base Pair
significantly more elaborate substituents could be tol-
erated.
midite, and the primers extended by conventionalEaton and coworkers were the first to show that T7
means to obtain full-length DNA complementary to theRNA polymerase could accept a UTP modified at the 5
desired RNA. Of course this strategy still requires thatposition with a relatively large substituent [14]. Vaish et
one has both a modified phosphoramidite and a comple-al. later demonstrated that other C5 side chains were
mentary nucleoside triphosphate. It will be of interesttolerated as well and introduced amino and thiol functional
to see if this technology can be translated into highergroups into RNA via T7 RNA polymerase-mediated tran-
throughput synthesis of sets of RNA molecules modifiedscription [15]. The ability to be able to incorporate sub-
at different sites. Complete mapping of interactions willstituents at this position has important implications for
likely require libraries of RNA molecules containingthe development of molecular tools in the RNA arena.
members each substituted at a different site. The advan-The demonstration by Kimoto et al. [1] that the 2-oxopyr-
tage of the Kimoto strategy is that automated synthesisidine base surrogate could also accommodate a substit-
of oligodeoxyribonucleotides is relatively inexpensive,uent at this position bodes well for future applications.
and potentially only a single modified nucleoside phos-For example, one could imagine adding C5 alkynyl spac-
phoramidite would be required. The economics of syn-ers terminating in reactive functional groups that provide
thesizing the complementary modified nucleoside tri-a pathway for the introduction of other crosslinking re-
phosphates could be more of an issue.agents, reporter groups, ligands, or other functionalities
Other alternatives for site-specific introduction ofuseful as tools for probing RNA interactions. For exam-
modified bases into RNA exist, and it will be interestingple, the introduction of other types of photo-crosslinking
to see how these competing strategies are used in thereagents would be useful [16].
next few years. Earnshaw and Gait reviewed methodol-One of the benefits of the technology reported by
ogy for site-specific introductions of modified nucleo-Hirao and coworkers is that one can introduce modified
sides into RNA 5 yr ago [17]. With recent improvementsbases into virtually any site within a long RNA, since the
in RNA synthesis and ligation technologies, it is likelyRNA is obtained by transcription off of a DNA template.
to become more routine to build oligoribonucleotidesThe modified base s can be incorporated into oligode-
oxyribonucleotide primers by means of its phosphora- containing photoaffinity labels at specific positions and
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